Point-of-care Cholesterol Monitoring Device Market Size, Share, Growth, Trends, and Forecast, 2032

According to the report published by Zion Market Research, the global Point-of-care Cholesterol Monitoring Device Market size was valued at USD 458.87 Million in 2023 and is predicted to reach USD 626.48 Million by the end of 2032. The market is expected to grow with a CAGR of 3.52% during the forecast period. 

Request Free Sample

Global Point-of-care Cholesterol Monitoring Device Market: Overview

Cholesterol testing is different from other tests. It is usually done to predict the risk of developing a disease, especially heart diseases rather than to monitor or diagnose a disease. Cholesterol is important for the proper functioning of the body, but high levels of cholesterol are harmful and may lead to heart problems. The point-of-care (POC) cholesterol monitoring devices used for screening of asymptomatic population provides numerous advantages as compared to conventional lab testing. This includes short turnaround time, testing of small blood samples, to obtain results no need to revisit the clinic, and no transportation of specimen.

Global Point-of-care Cholesterol Monitoring Device Market: Growth Factors

The global point-of-care cholesterol monitoring devices market is growing at a faster rate. Growing concerns regarding health issues has increased demand for POC cholesterol monitoring devices owing to its benefits, and rise in government initiatives to raise awareness regarding cardiovascular diseases are the prime factors that are propelling the growth of the global point-of-care cholesterol monitoring devices market. Heart disease is one of the leading causes of death globally. As per the report put forth by the American Heart Association, in 2017 around 116.4 million that is 46 percent of the adults in the US were predicted to have hypertension, and based on the data from 2016, around 389.4 deaths have occurred due to stroke each day.

In addition to this, there is a rise in the geriatric population across the world. They are at high risk of cardiac arrest, arteriosclerosis, and many more heart-related problems due to high cholesterol levels. Thus, it is essential to monitor cholesterol levels to avoid the risk of such diseases and POC cholesterol monitoring devices play a vital role in this. Moreover, unhealthy lifestyle, smoking habits, and lack of physical activity are the factors that are leading to cardiovascular diseases. This is ultimately boosting the growth of the global market. Furthermore, the inclination of people towards self-testing and advancements in technology may create huge opportunities for the growth of the global point-of-care cholesterol monitoring devices market during the forecast period. However, stringent regulations of the government for approval of devices may restrain the growth of the global point-of-care cholesterol monitoring devices market.

The Covid-19 pandemic has put the healthcare sector under immense pressure. On one hand, the number of patients was increasing rapidly and on the other hand, the resources to treat them were insufficient. All the healthcare professionals were shifted to treat Covid-19 patients. Thus, all other procedures except the ones with high risk were postponed. The people also preferred to stay home and avoided visiting clinics & hospitals for their routine checkup. Due to the shutdown of operations in the manufacturing unit, there was a decline in the manufacturing of the devices. The strict lockdown also disrupted the distribution chain. Owing to all these factors, the growth of the global point-of-care cholesterol monitoring devices market was slowed down amid the Covid-19 pandemic.

Request Free Sample

Global Point-of-care Cholesterol Monitoring Device Market: Segmentation

The global point-of-care cholesterol monitoring devices market is classified into the application, technology, product type, end-user, and region.

Based on the application, the global point-of-care cholesterol monitoring devices market is divided into arteriosclerosis, dyslipidemia, hypocholesterolemia, hypercholesterolemia, and others.

Based on the technology, the global market is bifurcated into reflectance photometry and electrochemical biosensor.

The product type segment is split into testing kits and instruments.

Based on the end-user, the market is categorized into home care settings, diagnostics centers & laboratory, ambulatory surgical care, and hospitals.

Point-of-care Cholesterol Monitoring Device Market: Report Scope

Global Point-of-care Cholesterol Monitoring Device Market: Regional Analysis

The global point-of-care cholesterol monitoring devices market is expected to be dominated by North America and retain its dominance during the forecast period. The rise in prevalence of cardiovascular diseases, rapid adoption of advanced technology, presence of key players, and growing geriatric population are some of the factors that are fueling the growth of the market in this region. Europe is the second-largest market and is estimated to account for a significant share of the market. On the other hand, the market in Asia Pacific is projected to grow with the highest CAGR owing to factors such as an increase in government initiatives to raise awareness regarding heart diseases and growing demand for home care testing.

Global Point-of-care Cholesterol Monitoring Device Market: Competitive Players

• Fitech UK Ltd.
• Bioptik Ltd.
• DiaSys Diagnostic Systems GmbH
• Jant Pharmacal Corporation
• SD Biosensor, Inc.
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Abaxis, Inc.
• Acon Laboratories, Inc.
• AccuTech, LLC

are the major players operating in the global point-of-care cholesterol monitoring devices market.

The Global Point-of-care Cholesterol Monitoring Device Market is segmented as follows:

By Application 

• arteriosclerosis 
• dyslipidemia 
• hypocholesterolemia 
• hypercholesterolemia
• and others 

By Technology 

• reflectance photometry
• electrochemical biosensor 

By Product type 

• testing kits 
• instruments 

By End-user 

• home care settings, 
• diagnostics centers & laboratory
• ambulatory surgical care
• hospitals 

Global Point-of-care Cholesterol Monitoring Device Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.